These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7702044)

  • 41. Effect of specimen order on Chlamydia trachomatis and Neisseria gonorrhoeae test performance and adequacy of Papanicolaou smear.
    Ghanem KG; Koumans EH; Johnson RE; Sawyer MK; Papp JR; Unger ER; Black CM; Markowitz LE
    J Pediatr Adolesc Gynecol; 2006 Feb; 19(1):23-30. PubMed ID: 16472725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pap smear adequacy.
    Steinbach A
    J Am Board Fam Pract; 1989; 2(4):294. PubMed ID: 2801202
    [No Abstract]   [Full Text] [Related]  

  • 43. The accuracy of physical diagnostic tests for assessing meniscal lesions of the knee: a meta-analysis.
    Scholten RJ; Devillé WL; Opstelten W; Bijl D; van der Plas CG; Bouter LM
    J Fam Pract; 2001 Nov; 50(11):938-44. PubMed ID: 11711009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The data-processing tool: an aid to implementation of quality assurance in a department of pathology. The example of Pap smears].
    Debaque H
    Ann Pathol; 2006 Oct; 26(5):375-81. PubMed ID: 17255926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Re: "Meta-analysis of Pap test accuracy".
    Boyko EJ
    Am J Epidemiol; 1996 Feb; 143(4):406-7. PubMed ID: 8633625
    [No Abstract]   [Full Text] [Related]  

  • 47. "Modernizing Cervical Cytology Screening with Liquid-Based Methods at Community-Level Hospitals: A Much-Needed Breakthrough for India".
    Tambvekar SE; Balsarkar G
    J Obstet Gynaecol India; 2024 Aug; 74(4):371-377. PubMed ID: 39280206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparing the Costs and Diagnostic Outcomes of Replacing Cytology with the QIAsure DNA Methylation Test as a Triage within HPV Primary Cervical Cancer Screening in The Netherlands.
    Puri Sudhir K; Kagenaar E; Meijer M; Hesselink AT; Adams E; Turner KME; Huntington S
    Diagnostics (Basel); 2023 Dec; 13(24):. PubMed ID: 38132196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and Evaluation of p16 based Double Antibody Sandwich ELISA for Detection of Cervical Precancer and Cancer.
    Bose M; Sunder Singh S; Ganesharaja S; Chiwate AS; Hingmire SJ; Rajkumar T
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2337-2346. PubMed ID: 37505764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance of screening tools for cervical neoplasia among women in low- and middle-income countries: A systematic review and meta-analysis.
    Smith SK; Nwosu O; Edwards A; Zerihun M; Chung MH; Suvada K; Ali MK
    PLOS Glob Public Health; 2023; 3(2):e0001598. PubMed ID: 36963095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meta-DiSc 2.0: a web application for meta-analysis of diagnostic test accuracy data.
    Plana MN; Arevalo-Rodriguez I; Fernández-García S; Soto J; Fabregate M; Pérez T; Roqué M; Zamora J
    BMC Med Res Methodol; 2022 Nov; 22(1):306. PubMed ID: 36443653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis of advanced cervical cancer, missed opportunities?
    Mattern J; Letendre I; Sibiude J; Pénager C; Jnifen A; Souare F; Ayel S; Nguyen T; Mandelbrot L
    BMC Womens Health; 2022 Mar; 22(1):97. PubMed ID: 35354463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Deep Learning Model for Cervical Cancer Screening on Liquid-Based Cytology Specimens in Whole Slide Images.
    Kanavati F; Hirose N; Ishii T; Fukuda A; Ichihara S; Tsuneki M
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Raman Imaging and Fluorescence Lifetime Imaging Microscopy for Diagnosis of Cancer State and Metabolic Monitoring.
    Becker L; Janssen N; Layland SL; Mürdter TE; Nies AT; Schenke-Layland K; Marzi J
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Robust whole slide image analysis for cervical cancer screening using deep learning.
    Cheng S; Liu S; Yu J; Rao G; Xiao Y; Han W; Zhu W; Lv X; Li N; Cai J; Wang Z; Feng X; Yang F; Geng X; Ma J; Li X; Wei Z; Zhang X; Quan T; Zeng S; Chen L; Hu J; Liu X
    Nat Commun; 2021 Sep; 12(1):5639. PubMed ID: 34561435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TOP2A/MCM2, p16
    Del Moral-Hernández O; Hernández-Sotelo D; Alarcón-Romero LDC; Mendoza-Catalán MA; Flores-Alfaro E; Castro-Coronel Y; Ortiz-Ortiz J; Leyva-Vázquez MA; Ortuño-Pineda C; Castro-Mora W; Illades-Aguiar B
    BMC Cancer; 2021 Jan; 21(1):39. PubMed ID: 33413211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cervical Cancer in Women with Normal Papanicolaou Tests: A Korean Nationwide Cohort Study.
    Kim M; Kim H; Suh DH; Kim YB
    Cancer Res Treat; 2021 Jul; 53(3):813-818. PubMed ID: 33321565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL.
    Bhuyan PK; Dallas M; Kraynyak K; Herring T; Morrow M; Boyer J; Duff S; Kim J; Weiner DB
    Hum Vaccin Immunother; 2021 May; 17(5):1288-1293. PubMed ID: 33175656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening for Cervical Cancer.
    Eun TJ; Perkins RB
    Med Clin North Am; 2020 Nov; 104(6):1063-1078. PubMed ID: 33099451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hybrid Transfer Learning for Classification of Uterine Cervix Images for Cervical Cancer Screening.
    Kudva V; Prasad K; Guruvare S
    J Digit Imaging; 2020 Jun; 33(3):619-631. PubMed ID: 31848896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.